• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大陆地区应用靶向二代测序技术评估与肾损害相关的结节性硬化症复合体

Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.

作者信息

Cai Yi, Li Hanzhong, Zhang Yushi

机构信息

Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Urology. 2017 Mar;101:170.e1-170.e7. doi: 10.1016/j.urology.2016.10.056. Epub 2017 Jan 5.

DOI:10.1016/j.urology.2016.10.056
PMID:28065512
Abstract

OBJECTIVE

To identify the TSC1 and TSC2 mutations in patients with tuberous sclerosis complex (TSC) associated with renal lesions, and to explore the relationship between genotypes and phenotypes.

MATERIALS AND METHODS

We analyzed 43 individuals affected with TSC accompanied by renal lesions using next-generation sequencing (NGS). We also performed Sanger sequencing to validate the NGS results.

RESULTS

We reported a comprehensive mutation analysis of 43 affected individuals with TSC accompanied by renal lesions using NGS. Forty-one of 43 patients (95%) had at least 1 detectable mutation in the TSC1 or TSC2 gene. We identified 14 novel nucleotide alterations, including 11 novel small mutations and 3 large-deletion mutations for the first time. Our study showed that patients with TSC2 mutations had higher frequency of hypomelanotic macules and dental enamel pits and larger angiomyolipomas (AMLs) than patient populations with non-TSC2 mutations through analysis of the correlated mutation findings with clinical features.

CONCLUSION

In conclusion, patients with TSC2 mutations had higher frequency of hypomelanotic macules and dental enamel pits, along with larger renal AMLs, compared with patient populations with non-TSC2 mutations. Patients with large deletions and frameshift mutations of the TSC1 or TSC2 gene showed larger AML diameters than patients with other kinds of mutations.

摘要

目的

鉴定与肾损害相关的结节性硬化症(TSC)患者的TSC1和TSC2突变,并探讨基因型与表型之间的关系。

材料与方法

我们使用下一代测序(NGS)分析了43例伴有肾损害的TSC患者。我们还进行了桑格测序以验证NGS结果。

结果

我们报告了使用NGS对43例伴有肾损害的TSC患者进行的全面突变分析。43例患者中有41例(95%)在TSC1或TSC2基因中至少有1个可检测到的突变。我们首次鉴定出14种新的核苷酸改变,包括11种新的小突变和3种大缺失突变。通过对相关突变结果与临床特征的分析,我们的研究表明,与非TSC2突变患者群体相比,TSC2突变患者的色素减退斑和牙釉质凹陷发生率更高,血管平滑肌脂肪瘤(AML)更大。

结论

总之,与非TSC2突变患者群体相比,TSC2突变患者的色素减退斑和牙釉质凹陷发生率更高,同时肾AML更大。TSC1或TSC2基因发生大缺失和移码突变的患者比其他类型突变的患者AML直径更大。

相似文献

1
Assessment of Tuberous Sclerosis Complex Associated With Renal Lesions by Targeted Next-generation Sequencing in Mainland China.中国大陆地区应用靶向二代测序技术评估与肾损害相关的结节性硬化症复合体
Urology. 2017 Mar;101:170.e1-170.e7. doi: 10.1016/j.urology.2016.10.056. Epub 2017 Jan 5.
2
Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.中国患者结节性硬化症:TSC1/TSC2 基因突变分析与表型研究。
Seizure. 2019 Oct;71:322-327. doi: 10.1016/j.seizure.2019.08.010. Epub 2019 Aug 23.
3
The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex.与结节性硬化症相关的肾血管平滑肌脂肪瘤中TSC2基因的突变和外显子缺失分析。
Exp Mol Pathol. 2014 Dec;97(3):440-4. doi: 10.1016/j.yexmp.2014.09.013. Epub 2014 Oct 1.
4
Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.通过TSC2变性梯度凝胶电泳(DGGE)、TSC1/TSC2多重连接探针扩增(MLPA)以及TSC1长片段PCR测序对65例结节性硬化症(TSC)患者进行分析,并报告28个新突变。
Hum Mutat. 2005 Oct;26(4):374-83. doi: 10.1002/humu.20227.
5
Novel TSC1 and TSC2 gene mutations in Chinese patients with tuberous sclerosis complex.中国结节性硬化症患者中TSC1和TSC2基因的新型突变
Clin Neurol Neurosurg. 2017 Mar;154:104-108. doi: 10.1016/j.clineuro.2017.01.015. Epub 2017 Feb 1.
6
Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.韩国结节性硬化症患者中TSC1和TSC2的突变分析。
Brain Dev. 2006 Aug;28(7):440-6. doi: 10.1016/j.braindev.2006.01.006. Epub 2006 Mar 22.
7
Screening for TSC1 and TSC2 mutations using NGS in Greek children with tuberous sclerosis syndrome.使用 NGS 在希腊结节性硬化症综合征患儿中进行 TSC1 和 TSC2 突变筛查。
Eur J Paediatr Neurol. 2018 May;22(3):419-426. doi: 10.1016/j.ejpn.2018.01.026. Epub 2018 Feb 9.
8
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.对224例结节性硬化症患者的队列进行的突变分析表明,与TSC1相比,TSC2疾病在多个器官中的严重程度增加。
Am J Hum Genet. 2001 Jan;68(1):64-80. doi: 10.1086/316951. Epub 2000 Dec 8.
9
Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.结节性硬化症:视网膜表现的基因型/表型相关性。
Ophthalmology. 2012 Sep;119(9):1917-23. doi: 10.1016/j.ophtha.2012.03.020. Epub 2012 May 16.
10
Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations.靶向新一代测序揭示了先前未被识别的TSC1和TSC2突变。
BMC Med Genet. 2015 Feb 25;16:10. doi: 10.1186/s12881-015-0155-4.

引用本文的文献

1
A recurrent variant c.5126C>T in a Han-Chinese family with tuberous sclerosis complex.一个患有结节性硬化症复合体的汉族家庭中出现的复发性变异c.5126C>T 。
Pak J Med Sci. 2025 Jan;41(1):263-268. doi: 10.12669/pjms.41.1.10153.
2
Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.结节性硬化症相关肾脏病变的临床实践推荐:常染色体显性遗传结构肾脏疾病 ERKNet 工作组和肾脏相关基因和疾病 ERA 工作组的共识声明。
Nat Rev Nephrol. 2024 Jun;20(6):402-420. doi: 10.1038/s41581-024-00818-0. Epub 2024 Mar 5.
3
The Importance of Genetic Testing in the Differential Diagnosis of Atypical TSC2-PKD1 Contiguous Gene Syndrome-Case Series.
基因检测在非典型TSC2-PKD1连续基因综合征鉴别诊断中的重要性——病例系列
Children (Basel). 2023 Feb 22;10(3):420. doi: 10.3390/children10030420.
4
Safety and Effectiveness of Medical Therapy and Surgical Intervention for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex.肾血管平滑肌脂肪瘤伴结节性硬化症的医学治疗和手术干预的安全性和有效性。
Cancer Control. 2022 Jan-Dec;29:10732748221140266. doi: 10.1177/10732748221140266.
5
Tuberous sclerosis complex with skin lesions as the initial presentation: A case report and multidisciplinary discussion.以皮肤损害为首发表现的结节性硬化症 1 例报告并多学科讨论
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jul 28;47(7):973-980. doi: 10.11817/j.issn.1672-7347.2022.210452.
6
Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China.中国12个结节性硬化症家系的临床特征分析及二代测序
Front Med (Lausanne). 2022 May 27;9:840709. doi: 10.3389/fmed.2022.840709. eCollection 2022.
7
Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations.不同类型TSC基因突变的中国结节性硬化症患者肾脏病变分析
Genet Mol Biol. 2022 May 27;45(2):e20200387. doi: 10.1590/1678-4685-GMB-2020-0387. eCollection 2022.
8
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex.低剂量依维莫司维持治疗与结节性硬化症相关的肾血管平滑肌脂肪瘤
Front Med (Lausanne). 2021 Nov 24;8:744050. doi: 10.3389/fmed.2021.744050. eCollection 2021.
9
High-throughput screening of circRNAs reveals novel mechanisms of tuberous sclerosis complex-related renal angiomyolipoma.高通量筛选环状 RNA 揭示了结节性硬化症相关肾血管平滑肌脂肪瘤的新机制。
Hum Genomics. 2021 Jul 9;15(1):43. doi: 10.1186/s40246-021-00344-1.
10
Mutational analysis of renal angiomyolipoma associated with tuberous sclerosis complex and the outcome of short-term everolimus therapy.肾血管平滑肌脂肪瘤与结节性硬化症相关的突变分析及短期依维莫司治疗的结果。
Sci Rep. 2019 Oct 4;9(1):14337. doi: 10.1038/s41598-019-49814-6.